- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/20 - Nitrogen atoms
Patent holdings for IPC class C07D 241/20
Total number of patents in this class: 598
10-year publication summary
|
32
|
40
|
48
|
47
|
45
|
37
|
33
|
35
|
31
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10829 |
33 |
| Nippon Shinyaku Co., Ltd. | 324 |
30 |
| Medibeacon, Inc. | 136 |
17 |
| Vertex Pharmaceuticals Incorporated | 1595 |
11 |
| Gilead Sciences, Inc. | 2038 |
11 |
| F. Hoffmann-La Roche AG | 7920 |
10 |
| Takeda Pharmaceutical Company Limited | 2696 |
10 |
| Agios Pharmaceuticals, Inc | 216 |
10 |
| Boehringer Ingelheim International GmbH | 4644 |
9 |
| Karyopharm Therapeutics Inc. | 142 |
9 |
| Corteva Agriscience LLC | 2664 |
9 |
| Dana-Farber Cancer Institute, Inc. | 2568 |
8 |
| Incyte Corporation | 1025 |
7 |
| Signal Pharmaceuticals, LLC | 179 |
7 |
| AstraZeneca AB | 2900 |
6 |
| Celgene Quanticel Research, Inc. | 163 |
6 |
| JNC Corporation | 1561 |
6 |
| Neoculi Pty Ltd | 18 |
6 |
| Janssen Pharmaceutica N.V. | 3384 |
5 |
| Arena Pharmaceuticals, Inc. | 365 |
5 |
| Other owners | 383 |